Magnus Spangsberg Boesen, Alfred Peter Born,Poul Erik Hyldgaard
Jensen, Finn Sellebjerg, MortenBlinkenberg, Magnus Christian Lydolph, Mikala
Klok Jørgensen, Lene Rosenberg, Jesper Qvist Thomassen, Malene Landbo Børresen. Diagnostic value of oligoclonal bands in
children: A nationwide population-based cohort study. Pediatric Neurology.
In press.
ABSTRACT
Objective
To evaluate the diagnostic value of cerebrospinal fluid
oligoclonal bands (OCBs) in children (<18 years).
Methods
In a nationwide population-based setting, we retrieved data
on 2,055 children’s OCB examination including concordant cerebrospinal fluid
biomarkers during 1994–2017. Case ascertainment was by review of medical
records and diagnostic codes. We used Fisher’s exact test to explore
distribution differences of OCB positivity in acquired demyelinating syndromes
(ADS) before and after 12 years of age and calculated sensitivity, specificity,
positive predictive value, and negative predictive value of OCBs to distinguish
ADS from the other diagnostic groups.
Results
Median age at OCB examination was 15.2 years
(range=1.8–18.0), and 10% had presence of cerebrospinal fluid OCB. OCB
positivity was the highest in ADS (52%), but it was age-dependent: 21% in
children with ADS before age 12 years and 68% in children 12–17 years
(p<0.0001) due to the higher incidence of multiple sclerosis in the latter.
Cerebrospinal fluid OCBs were not predictive of ADS before age 12 years
compared with the other diagnostic groups. However, cerebrospinal fluid OCBs in
children aged 12–17 years were highly predictive of ADS compared with CNS
infections and non-ADS immune-mediated CNS diseases (positive predictive value:
0.89; 95% confidence interval=0.82–0.94; p<0.0001), but negative OCBs were
not discriminatory (negative predictive value: p=0.17).
Conclusions
In a clinical setting, cerebrospinal fluid OCB examination
may be of higher yield in children aged 12–17 years if there is clinical
suspicion of multiple sclerosis, and in such circumstances a positive test
supports a diagnosis of multiple sclerosis.
Courtesy of Doximity
No comments:
Post a Comment